spirogermanium has been researched along with Prostatic Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blumenstein, B; Costanzi, JH; Crawford, ED; Saiers, JH; Slavik, M | 1 |
| Dexeus, FH; Hossan, B; Logothetis, C; Samuels, ML | 1 |
| Brunet, R; Bui, NB; Chauvergne, J; Hoerni, B; Lagarde, C; Le Guillou, M; Richaud, P | 1 |
3 other study(ies) available for spirogermanium and Prostatic Neoplasms
| Article | Year |
|---|---|
Phase II study of spirogermanium in advanced adenocarcinoma of the prostate: a Southwest Oncology Group Study.
Topics: Adenocarcinoma; Drug Evaluation; Humans; Male; Organometallic Compounds; Prostatic Neoplasms; Spiro Compounds | 1987 |
Phase II study of spirogermanium in metastatic prostate cancer.
Topics: Aged; Antineoplastic Agents; Drug Evaluation; Germanium; Humans; Male; Middle Aged; Neoplasm Metastasis; Organometallic Compounds; Prostatic Neoplasms; Spiro Compounds | 1986 |
[Metastatic cancer of the prostate: phase II study of spirogermanium (NSC 192965)].
Topics: Aged; Antineoplastic Agents; Drug Evaluation; Germanium; Humans; Male; Middle Aged; Neoplasm Metastasis; Organometallic Compounds; Prostatic Neoplasms; Spiro Compounds | 1986 |